Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 5
ClinicoEconomics and Outcomes Research
ISSN: 1178-6981
- View all (844)
- Volume 15, 2023 (64)
- Volume 14, 2022 (61)
- Volume 13, 2021 (90)
- Volume 12, 2020 (70)
- Volume 11, 2019 (71)
- Volume 10, 2018 (77)
- Volume 9, 2017 (77)
- Volume 8, 2016 (73)
- Volume 7, 2015 (64)
- Volume 6, 2014 (53)
- Volume 5, 2013 (59)
- Volume 4, 2012 (41)
- Volume 3, 2011 (19)
- Volume 2, 2010 (16)
- Volume 1, 2009 (9)
Archive: Volume 5, 2013
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia
Mencacci C, Aguglia E, Biggio G, Cappellari L, Di Sciascio G, Fagiolini A, Maina G, Tortorella A, Katz P, Ripellino C
ClinicoEconomics and Outcomes Research 2013, 5:611-621
Published Date: 3 December 2013
Health economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgia
Liedgens H, Obradovic M, Nuijten M
ClinicoEconomics and Outcomes Research 2013, 5:597-609
Published Date: 25 November 2013
Persistence with weekly and monthly bisphosphonates among postmenopausal women: analysis of a US pharmacy claims administrative database
Fan T, Zhang Q, Sen SS
ClinicoEconomics and Outcomes Research 2013, 5:589-595
Published Date: 19 November 2013
Comparison of the costs of nonoperative care to minimally invasive surgery for sacroiliac joint disruption and degenerative sacroiliitis in a United States Medicare population: potential economic implications of a new minimally-invasive technology
Ackerman SJ, Polly Jr DW, Knight T, Schneider K, Holt T, Cummings J
ClinicoEconomics and Outcomes Research 2013, 5:575-587
Published Date: 20 November 2013
Challenges in measuring and valuing productivity costs, and their relevance in mood disorders
Lensberg BR, Drummond MF, Danchenko N, Despiégel N, François C
ClinicoEconomics and Outcomes Research 2013, 5:565-573
Published Date: 18 November 2013
Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference values
Dunlop W, Iqbal I, Khan I, Ouwens M, Heron L
ClinicoEconomics and Outcomes Research 2013, 5:555-564
Published Date: 30 October 2013
Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy
Foroutan N, Rasekh HR, Salamzadeh J, Jamshidi HR, Nafar M
ClinicoEconomics and Outcomes Research 2013, 5:545-553
Published Date: 18 October 2013
A systematic review of the effectiveness of taxes on nonalcoholic beverages and high-in-fat foods as a means to prevent obesity trends
Maniadakis N, Kapaki V, Damianidi L, Kourlaba G
ClinicoEconomics and Outcomes Research 2013, 5:519-543
Published Date: 22 October 2013
Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups
Campbell RS, Chaudhari P, Hays HD, Taylor RJ, Nathanson BH, Bozzette SA, Horn DL
ClinicoEconomics and Outcomes Research 2013, 5:507-517
Published Date: 24 October 2013
Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs
Baser O, Tangirala K, Wei W, Xie L
ClinicoEconomics and Outcomes Research 2013, 5:497-505
Published Date: 3 October 2013
Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines
Colombo GL, Matteo SD, Antinori A, Medaglia M, Murachelli S, Rizzardini G
ClinicoEconomics and Outcomes Research 2013, 5:489-496
Published Date: 3 October 2013
Cost of noninfectious comorbidities in patients with HIV
Guaraldi G, Zona S, Menozzi M, Carli F, Bagni P, Berti A, Rossi E, Orlando G, Zoboli G, Palella F
ClinicoEconomics and Outcomes Research 2013, 5:481-488
Published Date: 23 September 2013
Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery device
Grabner M, Chen Y, Nguyen M, Abbott SD, Quimbo R
ClinicoEconomics and Outcomes Research 2013, 5:471-479
Published Date: 23 September 2013
Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
O'Day K, Rajagopalan K, Meyer K, Pikalov A, Loebel A
ClinicoEconomics and Outcomes Research 2013, 5:459-470
Published Date: 13 September 2013
Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin
Stephens JM, Gao X, Patel DA, Verheggen BG, Shelbaya A, Haider S
ClinicoEconomics and Outcomes Research 2013, 5:447-457
Published Date: 16 September 2013
Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US
Juday T, Correll T, Anene A, Broder MS, Ortendahl J, Bentley T
ClinicoEconomics and Outcomes Research 2013, 5:437-445
Published Date: 2 September 2013
Early enteral nutrition in critical illness: a full economic analysis using US costs
Doig GS, Chevrou-Séverac H, Simpson F
ClinicoEconomics and Outcomes Research 2013, 5:429-436
Published Date: 23 August 2013
Cost and clinical consequences of smoking cessation in outpatients after cardiovascular disease: a retrospective cohort study
Sicras-Mainar A, Díaz-Cerezo S, Sanz de Burgoa V, Navarro-Artieda R
ClinicoEconomics and Outcomes Research 2013, 5:419-427
Published Date: 19 August 2013
The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy
Montgomery W, Liu L, Stensland MD, Xue HB, Treuer T, Ascher-Svanum H
ClinicoEconomics and Outcomes Research 2013, 5:407-418
Published Date: 14 August 2013
Impact of scribes on patient interaction, productivity, and revenue in a cardiology clinic: a prospective study
Bank AJ, Obetz C, Konrardy A, Khan A, Pillai KM, McKinley BJ, Gage RM, Turnbull MA, Kenney WO
ClinicoEconomics and Outcomes Research 2013, 5:399-406
Published Date: 9 August 2013
Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden
Wex J, Abou-Setta AM
ClinicoEconomics and Outcomes Research 2013, 5:381-397
Published Date: 9 August 2013
Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a full economic analysis of a multicenter randomized controlled trial based on US costs
Doig GS, Simpson F
ClinicoEconomics and Outcomes Research 2013, 5:369-379
Published Date: 22 July 2013
Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study
Kiiskinen U, Matthaei S, Reaney M, Mathieu C, Östenson C-G, Krarup T, Theodorakis M, Kiljański J, Salaun-Martin C, Sapin H, Guerci B
ClinicoEconomics and Outcomes Research 2013, 5:355-367
Published Date: 11 July 2013
Retrospective claims analysis of best supportive care costs and survival in a US metastatic renal cell population
Henk HJ, Chen C, Benedict A, Sullivan J, Teitelbaum A
ClinicoEconomics and Outcomes Research 2013, 5:347-354
Published Date: 9 July 2013
Changes in quality of care and costs induced by implementation of a diabetes program in a social security entity of Argentina
González L, Elgart JF, Calvo H, Gagliardino JJ
ClinicoEconomics and Outcomes Research 2013, 5:337-345
Published Date: 4 July 2013
Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
Darbà J, Pérez-Álvarez N, Kaskens L, Holgado-Pérez S, Racketa J, Rejas J
ClinicoEconomics and Outcomes Research 2013, 5:327-336
Published Date: 5 July 2013
Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4
Borghi C, Ambrosioni E, Omboni S, Cicero AFG, Bacchelli S, Degli Esposti D, Novo S, Vinereanu D, Ambrosio G, Reggiardo G, Zava D
ClinicoEconomics and Outcomes Research 2013, 5:317-325
Published Date: 8 July 2013
A cost-of-illness study of spina bifida in Italy
Colombo GL, Di Matteo S, Vinci M, Gatti C, Pascali MP, De Gennaro M, Macrellino E, Mosiello G, Redaelli T, Schioppa F, Dieci C
ClinicoEconomics and Outcomes Research 2013, 5:309-316
Published Date: 2 July 2013
Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model
Lee HY, Yang BM, Hong JM, Lee TJ, Kim BG, Kim JW, Kim YT, Kim YM, Kang S
ClinicoEconomics and Outcomes Research 2013, 5:297-307
Published Date: 3 July 2013
Fluid overload is associated with increases in length of stay and hospital costs: pooled analysis of data from more than 600 US hospitals
Magee G, Zbrozek A
ClinicoEconomics and Outcomes Research 2013, 5:289-296
Published Date: 26 June 2013
The costs of traumatic brain injury: a literature review
Humphreys I, Wood RL, Phillips CJ, Macey S
ClinicoEconomics and Outcomes Research 2013, 5:281-287
Published Date: 26 June 2013
Demographics and clinical and economic characteristics of patients receiving total hip arthroplasty with and without muscle atrophy/weakness
Wu N, Chen SY, Lee YC, Zhao Y
ClinicoEconomics and Outcomes Research 2013, 5:271-280
Published Date: 25 June 2013
Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation
Wex J, Sidhu M, Odeyemi I, Abou-Setta AM, Retsa P, Tombal B
ClinicoEconomics and Outcomes Research 2013, 5:257-269
Published Date: 24 June 2013
Estimating the long-term effects of in vitro fertilization in Greece: an analysis based on a lifetime-investment model
Fragoulakis V, Maniadakis N
ClinicoEconomics and Outcomes Research 2013, 5:247-255
Published Date: 20 June 2013
The clinical and economic burden of chronic obstructive pulmonary disease in the USA
Guarascio AJ, Ray SM, Finch CK, Self TH
ClinicoEconomics and Outcomes Research 2013, 5:235-245
Published Date: 17 June 2013
Medical technology as a key driver of rising health expenditure: disentangling the relationship
Sorenson C, Drummond M, Bhuiyan Khan B
ClinicoEconomics and Outcomes Research 2013, 5:223-234
Published Date: 30 May 2013
Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain
Llibre JM, Cardona G, Santos JR, Andreu A , Estrada JO, Ara J, Bonafont X, Clotet B
ClinicoEconomics and Outcomes Research 2013, 5:215-221
Published Date: 23 May 2013
Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany
Klussmann JP, Schädlich PK, Chen X, Rémy V
ClinicoEconomics and Outcomes Research 2013, 5:203-213
Published Date: 16 May 2013
Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases
Degli Esposti L, Saragoni S, Buda S, Sturani A, Degli Esposti E
ClinicoEconomics and Outcomes Research 2013, 5:193-201
Published Date: 14 May 2013
Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey
Walzer S, Travers K, Rieder S, Erazo-Fischer E, Matusiewicz D
ClinicoEconomics and Outcomes Research 2013, 5:189-192
Published Date: 3 May 2013
Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population
Chen SY, Crivera C, Stokes M, Boulanger L, Schein J
ClinicoEconomics and Outcomes Research 2013, 5:181-188
Published Date: 1 May 2013
Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States
Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S
ClinicoEconomics and Outcomes Research 2013, 5:171-180
Published Date: 23 April 2013
Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy
Mody R, Eisenberg D, Hou L, Kamat S, Singer J, Gerson LB
ClinicoEconomics and Outcomes Research 2013, 5:161-169
Published Date: 22 April 2013
Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy management
Pinto SL, Kumar J, Partha G, Bechtol RA
ClinicoEconomics and Outcomes Research 2013, 5:153-159
Published Date: 11 April 2013
Update on the management of cirrhosis – focus on cost-effective preventative strategies
Neff GW, Kemmer N, Duncan C, Alsina A
ClinicoEconomics and Outcomes Research 2013, 5:143-152
Published Date: 12 April 2013
Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents
Vergnenègre A, Borget I, Chouaid C
ClinicoEconomics and Outcomes Research 2013, 5:137-141
Published Date: 10 April 2013
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
Lazzaro C, Bordonaro R, Cognetti F, Fabi A, De Placido S, Arpino G, Marchetti P, Botticelli A, Pronzato P, Martelli E
ClinicoEconomics and Outcomes Research 2013, 5:125-135
Published Date: 11 April 2013
Follow-up analysis of federal process of care data reported from three acute care hospitals in rural Appalachia
Sills ES, Chiriac L, Vaughan D, Jones CA, Salem SA
ClinicoEconomics and Outcomes Research 2013, 5:119-124
Published Date: 27 March 2013
The role and uptake of private health insurance in different health care systems: are there lessons for developing countries?
Odeyemi IA, Nixon J
ClinicoEconomics and Outcomes Research 2013, 5:109-118
Published Date: 5 March 2013
Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States
Khorana AA, Dalal MR, Lin J, Connolly GC
ClinicoEconomics and Outcomes Research 2013, 5:101-108
Published Date: 13 February 2013
Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
Mencacci C, Di Sciascio G, Katz P, Ripellino C
ClinicoEconomics and Outcomes Research 2013, 5:87-99
Published Date: 7 February 2013
Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions
Spinner DS, Birt J, Walter JW, Bowman L, Mauskopf J, Drummond MF, Copley-Merriman C
ClinicoEconomics and Outcomes Research 2013, 5:69-85
Published Date: 30 January 2013
Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen
Colombo GL, Di Matteo S, Maggiolo F
ClinicoEconomics and Outcomes Research 2013, 5:59-68
Published Date: 12 February 2013
Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy
Nadkarni A, Kalsekar I, You M, Forbes R, Hebden T
ClinicoEconomics and Outcomes Research 2013, 5:49-57
Published Date: 20 January 2013
Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research Database
Reed C, Hong J, Novick D, Lenox-Smith A, Happich M
ClinicoEconomics and Outcomes Research 2013, 5:37-47
Published Date: 14 January 2013
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
Thavorncharoensap M, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P
ClinicoEconomics and Outcomes Research 2013, 5:29-36
Published Date: 10 January 2013
Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model
Reynolds MR, Nilsson J, Åkerborg Ö, Jhaveri M, Lindgren P
ClinicoEconomics and Outcomes Research 2013, 5:19-28
Published Date: 8 January 2013
Epidemiology of falls and osteoporotic fractures: a systematic review
Morrison A, Fan T, Sen SS, Weisenfluh L
ClinicoEconomics and Outcomes Research 2013, 5:9-18
Published Date: 28 December 2012
Analysis of disease patterns and cost of treatments for prevention of deep venous thrombosis after total knee or hip replacement: results from the Practice Analysis of THromboprophylaxis after Orthopaedic Surgery (PATHOS) study
Degli Esposti L, Didoni G, Simon T, Buda S, Sangiorgi D, Degli Esposti E
ClinicoEconomics and Outcomes Research 2013, 5:1-7
Published Date: 28 December 2012